Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,400.00p
   
  • Change Today:
      50.00p
  • 52 Week High: 4,750.00
  • 52 Week Low: 2,200.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 16,526
  • Market Cap: £125.27m
  • Beta: 0.00

Latest Deals

Traded Action Notifier PriceAmountValue
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
29-Apr-24 Buy Bruce Hiscock 4,552.00p 11 £500.72

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-Oct-24 Buy Bruce Hiscock 3,330.00p 300 £9,990.00
22-Nov-24 Buy Bruce Hiscock 3,822.00p 24 £917.28
29-Apr-24 Buy Bruce Hiscock 4,552.00p 11 £500.72
23-Dec-24 Buy Bruce Hiscock 273.00p 61 £166.53

Director Shareholdings

Notifier Holding Value*
Peter John Harrison 297,088 £7,130,112
Ian James Nicholson 13,000 £312,000
Bruce Hiscock 1,174 £28,176

Major Shareholders

Notifier** Holding Value*
Rathbones Investment Management Ltd 5,219,656 £125,271,744
Castlefield Fund Partners Limited 985,000 £23,640,000
SANFORD DELAND ASSET MANAGEMENT LTD 885,000 £21,240,000
Gresham House Asset Management Limited 627,782 £15,066,768
SANFORD DELAND ASSET MANAGEMENT LTD 619,500 £14,868,000
Miton Group plc 508,135 £12,195,240
The Diverse Income Trust plc 302,300 £7,255,200
Schroders plc 284,795 £6,835,080
Wasatch Advisors, Inc. 265,000 £6,360,000
Canaccord Genuity Group Inc 259,940 £6,238,560
Adrian Williams 253,372 £6,080,928

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,400.00p
Change Today 50.00p
% Change 2.13 %
52 Week High 4,750.00
52 Week Low 2,200.00
Volume 16,526
Shares Issued 5.22m
Market Cap £125.27m
Beta 0.00

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average38.85% below the market average
87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average87.50% above the sector average
Price Trend
72.7% below the market average72.7% below the market average72.7% below the market average72.7% below the market average72.7% below the market average
34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average34.69% below the sector average
Income
40.81% above the market average40.81% above the market average40.81% above the market average40.81% above the market average40.81% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
26% below the market average26% below the market average26% below the market average26% below the market average26% below the market average
29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average29.03% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 07-Apr-2025

Time Volume / Share Price
16:45 100 @ 2,400.00p
16:11 120 @ 2,441.00p
15:33 250 @ 2,500.00p
15:29 500 @ 2,490.00p
14:07 1,792 @ 2,300.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page